Corcept Therapeutics (CORT) Meets Q1 Earnings Estimates
Corcept Therapeutics (CORT) came out with quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items.
A quarter ago, it was expected that this drug developer would post earnings of $0.37 per share when it actually produced earnings of $0.26, delivering a surprise of -29.73%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Corcept , which belongs to the Zacks Medical - Drugs industry, posted revenues of $157.21 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 11.66%. This compares to year-ago revenues of $146.81 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Corcept shares have added about 44.4% since the beginning of the year versus the S&P 500's decline of -3.3%.
While Corcept has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Corcept: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.40 on $216.49 million in revenues for the coming quarter and $1.76 on $905.68 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Drugs is currently in the top 25% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Xeris Biopharma (XERS), is yet to report results for the quarter ended March 2025. The results are expected to be released on May 8.
This company is expected to post quarterly loss of $0.07 per share in its upcoming report, which represents a year-over-year change of +50%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Xeris Biopharma's revenues are expected to be $57.39 million, up 41.2% from the year-ago quarter.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Corcept Therapeutics Incorporated (CORT) : Free Stock Analysis Report
Xeris Biopharma Holdings, Inc. (XERS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Dave & Buster's (PLAY) Q1 Earnings Lag Estimates
Dave & Buster's (PLAY) came out with quarterly earnings of $0.76 per share, missing the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $1.12 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -20.83%. A quarter ago, it was expected that this owner of Dave & Buster's, a chain of restaurants and arcades would post earnings of $0.64 per share when it actually produced earnings of $0.69, delivering a surprise of 7.81%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Dave & Buster's , which belongs to the Zacks Retail - Restaurants industry, posted revenues of $567.7 million for the quarter ended April 2025, surpassing the Zacks Consensus Estimate by 0.74%. This compares to year-ago revenues of $588.1 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Dave & Buster's shares have lost about 12.4% since the beginning of the year versus the S&P 500's gain of 2.1%. While Dave & Buster's has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Dave & Buster's: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #5 (Strong Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.81 on $549.08 million in revenues for the coming quarter and $1.69 on $2.14 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Retail - Restaurants is currently in the bottom 25% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, Darden Restaurants (DRI), is yet to report results for the quarter ended May 2025. The results are expected to be released on June 20. This owner of Olive Garden and other chain restaurants is expected to post quarterly earnings of $2.92 per share in its upcoming report, which represents a year-over-year change of +10.2%. The consensus EPS estimate for the quarter has been revised 0.6% lower over the last 30 days to the current level. Darden Restaurants' revenues are expected to be $3.25 billion, up 10% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Dave & Buster's Entertainment, Inc. (PLAY) : Free Stock Analysis Report Darden Restaurants, Inc. (DRI) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
34 minutes ago
- Yahoo
Stitch Fix (SFIX) Reports Q3 Loss, Tops Revenue Estimates
Stitch Fix (SFIX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.15 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 50%. A quarter ago, it was expected that this online clothing styling service would post a loss of $0.11 per share when it actually produced a loss of $0.05, delivering a surprise of 54.55%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Stitch Fix , which belongs to the Zacks Retail - Apparel and Shoes industry, posted revenues of $325.02 million for the quarter ended April 2025, surpassing the Zacks Consensus Estimate by 3.07%. This compares to year-ago revenues of $322.73 million. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Stitch Fix shares have added about 9.7% since the beginning of the year versus the S&P 500's gain of 2.1%. While Stitch Fix has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Stitch Fix: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.14 on $287.79 million in revenues for the coming quarter and -$0.35 on $1.23 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Retail - Apparel and Shoes is currently in the bottom 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. (JILL), another stock in the same industry, has yet to report results for the quarter ended April 2025. The results are expected to be released on June 11. This retailer of women's clothes, shoes and accessories is expected to post quarterly earnings of $0.88 per share in its upcoming report, which represents a year-over-year change of -27.9%. The consensus EPS estimate for the quarter has been revised 0.5% higher over the last 30 days to the current level. revenues are expected to be $156.67 million, down 3% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Stitch Fix, Inc. (SFIX) : Free Stock Analysis Report Inc. (JILL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
34 minutes ago
- Yahoo
Here's What Key Metrics Tell Us About Dave & Buster's (PLAY) Q1 Earnings
For the quarter ended April 2025, Dave & Buster's (PLAY) reported revenue of $567.7 million, down 3.5% over the same period last year. EPS came in at $0.76, compared to $1.12 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $563.52 million, representing a surprise of +0.74%. The company delivered an EPS surprise of -20.83%, with the consensus EPS estimate being $0.96. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Dave & Buster's performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Comparable Store Sales - Total: -8.3% versus -7.4% estimated by six analysts on average. Stores Count - End of Period: 236 versus the six-analyst average estimate of 235. Company-owned stores at end of period - Dave & Buster's: 175 versus the four-analyst average estimate of 173. Company-owned stores at end of period - Main Event: 61 versus 61 estimated by four analysts on average. Entertainment revenues: $366.60 million versus the six-analyst average estimate of $370.27 million. The reported number represents a year-over-year change of -5%. Food and beverage revenues: $201.10 million versus $193.21 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -0.6% change. View all Key Company Metrics for Dave & Buster's here>>>Shares of Dave & Buster's have returned +15.6% over the past month versus the Zacks S&P 500 composite's +6.3% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Dave & Buster's Entertainment, Inc. (PLAY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
